ADMA FY 2018 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M-25.4% YoY

Gross Profit

-$25M-148.4% margin

Operating Income

-$60M-354.9% margin

Net Income

-$66M-387.1% margin

EPS (Diluted)

$-1.45

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$65M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$89M

Total Liabilities

$69M

Stockholders' Equity

$20M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$23M	-25.4%
Gross Profit	-$25M	-$6M	-293.7%
Operating Income	-$60M	-$39M	-53.4%
Net Income	-$66M	-$44M	-50.2%